Discovery and Control of Succinimide Formation and Accumulation at Aspartic Acid Residues in The Complementarity-Determining Region of a Therapeutic Monoclonal Antibody-Reference-Cited by-同舟云学术

Discovery and Control of Succinimide Formation and Accumulation at Aspartic Acid Residues in The Complementarity-Determining Region of a Therapeutic Monoclonal Antibody

Published:2023-01-10 Issue:6 Volume:40 Page:1411-1423
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

VanAernum Zachary L.,Sergi Joseph A.,Dey Monisha,Toner Timothy,Kilgore Bruce,Lay-Fortenbery Ashley,Wang Yi,Bian Shengjie,Kochert Brent A.,Bothe Jameson R.,Gao Xinliu,Richardson Douglas,Schuessler Hillary A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s11095-022-03462-0.pdf

Reference51 articles.

1. Liu JKH. The history of monoclonal antibody development – Progress, remaining challenges and future innovations. Ann Med Surg. 2014;3:113–6.

2. Alt N, Zhang TY, Motchnik P, Taticek R, Quarmby V, Schlothauer T, Beck H, Emrich T. Harris RJ Determination of critical quality attributes for monoclonal antibodies using quality by design principles. Biologicals. 2016;44:291–305.

3. Le Basle Y, Chennell P, Tokhadze N, Astier A. Sautou V Physicochemical Stability of Monoclonal Antibodies: A Review. J Pharm Sci. 2020;109:169–90.

4. Kaur H. Stability testing in monoclonal antibodies. Crit Rev Biotechnol. 2021;41:692–714.

5. Liu H, Caza-Bulseco G, Faldu D, Chumsae C. Sun J Heterogeneity of Monoclonal Antibodies. J Pharm Sci. 2008;97:2426–47.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Titer and charge-based heterogeneity multiattribute monitoring of mAbs in cell culture harvest using 2D ProA CEX MS;Talanta;2024-08

2. Stability of Protein Pharmaceuticals: Recent Advances;Pharmaceutical Research;2024-06-27

3. LC–MS Approach to Decipher a Light Chain Chromatographic Peak Splitting of a Monoclonal Antibody;Pharmaceutical Research;2023-11-07

4. Enabling Efficient Design of Biological Formulations through Advanced Characterizations;Pharmaceutical Research;2023-06